Functional expression of human prostaglandin E2 receptor 4 (EP4) in E. coli and characterization of the binding property of EP4 with Gα proteins

被引:7
|
作者
Kim, Nam Hyuk [1 ]
Kim, Key-Sun [2 ]
Shin, Sang Chul [3 ]
Kim, Eunice Eunkyeong [3 ]
Yu, Yeon Gyu [1 ]
机构
[1] Kookmin Univ, Dept Chem, 77 Jeongneung Ro, Seoul 02707, South Korea
[2] Korea Inst Sci & Technol, Convergence Res Ctr Diag Treatment & Care Syst De, Seoul, South Korea
[3] Korea Inst Sci & Technol, Biomed Res Inst, Seoul 02790, South Korea
基金
新加坡国家研究基金会;
关键词
EP4; GPCR; PGE2; Overexpression; Purification; G protein; IN-VITRO; INFLAMMATION; CDNA;
D O I
10.1016/j.bbrep.2020.100871
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human prostaglandin E2 receptor 4 (EP4) is one of the four subtypes of prostaglandin E-2 (PGE(2)) receptors and belongs to the rhodopsin-type G protein-coupled receptor (GPCR) family. Particularly, EP4 is expressed in various cancer cells and is involved in cancer-cell proliferation by a G protein signaling cascade. To prepare an active form of EP4 for biochemical characterization and pharmaceutical application, this study designed a recombinant protein comprising human EP4 fused to the P9 protein (a major envelope protein of phi6 phage) and overexpressed the P9-EP4 fusion protein in the membrane fraction of E. coli. The solubilized P9-EP4 with sarkosyl (a strong anionic detergent) was purified by affinity chromatography. The purified protein was stabilized with amphiphilic polymers derived from poly-gamma-glutamate. The polymer-stabilized P9-EP4 showed specific interaction with the alpha subunits of G(s) or G(i) proteins, and a high content of alpha-helical structure by a circular dichroism spectroscopy. Furthermore, the polymer-stabilized P9-EP4 showed strong heat resistance compared with P9-EP4 in detergents. The functional preparation of EP4 and its stabilization with amphiphilic polymers could facilitate both the biochemical characterization and pharmacological applications targeting EP4.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope
    Bhattacharya, M
    Peri, K
    Ribeiro-da-Silva, A
    Almazan, G
    Shichi, H
    Hou, X
    Varma, DR
    Chemtob, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (22) : 15719 - 15724
  • [22] Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor
    Takayama, K
    García-Cardeña, G
    Sukhova, GK
    Comander, J
    Gimbrone, MA
    Libby, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) : 44147 - 44154
  • [24] Expression and regulation of the rat prostaglandin E2 receptor type 4 (EP4) in pregnant cervical tissue
    Chien, EK
    MacGregor, C
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (05) : 1501 - 1510
  • [25] Expression of the prostaglandin E2 receptors EP1, EP2, EP3 and EP4 in human kidney
    Morath, R
    Klein, T
    Seyberth, HW
    Nüsing, RM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R725 - R725
  • [26] Localization of prostaglandin E2 EP2 and EP4 receptors in the rat kidney
    Jensen, BL
    Stubbe, J
    Hansen, PB
    Andreasen, D
    Skott, O
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 280 (06) : F1001 - F1009
  • [27] The tumor promoting activity of the prostaglandin E2 EP4 receptor in mouse skin
    Simper, Melissa S.
    Bowen, Rebecca A.
    Surh, Inok
    Fischer, Susan M.
    CANCER RESEARCH, 2011, 71
  • [28] Prostaglandin E2 Receptor EP4 Inhibition Contracts Rat Ductus Arteriosus
    Sakuma, Toshiki
    Akaike, Toru
    Minamisawa, Susumu
    CIRCULATION JOURNAL, 2019, 83 (01) : 209 - 216
  • [29] The prostaglandin E2 EP4 receptor is pro-tumorigenic in mouse skin
    Simper, Melissa
    Bowen, Rebecca
    Surh, Inok
    Fischer, Susan
    CANCER RESEARCH, 2009, 69
  • [30] Role of the prostaglandin E2 receptor subtype EP4 in ischemic brain injury
    Kojima, Fumiaki
    Ri, Akimasa
    Yuhki, Koh-ichi
    Suzuki, Yasuhiro
    Kashiwagi, Hitoshi
    Narumiya, Shuh
    Ushikubi, Fumitaka
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 79P - 79P